Product image of Stamicis (Copper Tetramibi Tetrafluoroborate) supplied by GNH India

Stamicis

Active Ingredient:
Copper Tetramibi Tetrafluoroborate
Origin:
EU

Stamicis (Copper Tetramibi Tetrafluoroborate)

Stamicis (Copper Tetramibi Tetrafluoroborate) is an intravenous radiopharmaceutical used in diagnostic imaging procedures. It supports nuclear medicine evaluations by highlighting metabolic activity in tissues. This agent is commonly utilized for cardiac and oncologic assessments. Always administered under professional supervision.

Manufacturer / TM Owner

Cis Bio International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Stamicis is primarily used as a diagnostic aid in nuclear medicine imaging. It helps visualize metabolic processes in tissues, supporting the evaluation of cardiac function and tumor detection. The agent is particularly useful in procedures where functional imaging provides critical insights. It is not intended for therapeutic purposes.

Side Effects

  • After administration, Stamicis distributes through the body, accumulating in areas of high metabolic activity. This allows imaging equipment to capture detailed functional information. Patients may experience mild discomfort at the injection site. Effects are typically transient and resolve as the agent clears the system.

Precautions & Warnings

  • Stamicis should only be handled and administered by trained healthcare professionals. Pregnant or breastfeeding individuals should avoid exposure due to potential risks. Patients with known allergies to components of the formulation should inform their provider. Proper disposal of radioactive materials is essential.

Avoid Interactions

  • No specific drug interactions have been widely documented for Stamicis. However, medications affecting metabolic activity may theoretically influence imaging results. Patients should disclose all current medications to their healthcare provider. Alcohol consumption is generally discouraged before imaging procedures.

Frequently Asked Questions

Stamicis is used as a diagnostic radiopharmaceutical in nuclear medicine imaging to highlight metabolic activity in tissues.

Stamicis is administered intravenously by a healthcare professional during imaging procedures.

Mild discomfort at the injection site is the most commonly reported effect. Effects are typically transient.

Pregnant or breastfeeding individuals and those with known allergies to its components should avoid exposure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Copper Tetramibi Tetrafluoroborate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT